Abstract Submission + Guidelines - ASCCP 2027 Annual Meeting. Online registration by Cvent

General Requirements

Abstracts that have been presented previously (within the past year) are eligible. However, manuscripts based on the submitted work are NOT eligible if they have already been published in any journal prior to submission, or if they will be published before presentation at ASCCP’s Annual Meeting.
Abstracts must follow the submission guidelines below. ASCCP reserves the right to refuse review of an abstract if it does not conform to all submission requirements.
Case reports are rarely appropriate, unless they provide new insights and teach something important and true.
If accepted, the abstract will be published in the Journal of Lower Genital Tract Disease. Late-breaking abstracts are not published in the journal.
ASCCP is not responsible for copy editing for the Journal.
ASCCP membership is not required for any presenting author or co-author of a submitted abstract.
There are no restrictions on the number of abstracts one can submit, but a person may only be designated as presenter on a maximum of two abstract submissions.

Oral Presentations

Only a limited number of abstracts will be accepted for oral presentations. Submissions of top-scoring abstracts will be invited to present their work from the podium at specific sessions during the ASCCP Annual Meeting.
Oral presentations are limited to 10 minutes. You will be informed of the length of time available for your presentation after your abstract is accepted and once the meeting schedule is finalized.
Any abstracts not selected for oral abstract presentations will be considered for a poster presentation.
Employees of commercial interests, and topics related to products of commercial interests, cannot submit for oral abstracts.

Poster Presentations

Posters will be presented as a physical printed poster board. ASCCP will print all posters.

On-Line Submission

Regular abstracts must be submitted online via ASCCP’s website and must be completed by October 9, 2026 (11:59 PM, Eastern).
All required fields on the abstract submission webpage must be completed.
Relevant Financial Relationship (RFR) fields MUST be completed with ACCURATE information.
Submissions must present both proposed and completed data sets.

Format Specifications

Abstract title must not be more than 120 characters, including spaces, and cannot be changed after submission. Do not use uncommon abbreviations or acronyms in the title. Capitalize the first letter and use lower case letters unless a specific word or words is/are ordinarily capitalized.
Do not use brand or trade names in the title or in the presentation. Any presentation focused on products or presented by employees of commercial interests cannot be accepted for ORAL abstracts due to ACCME regulations. Please submit these as POSTER abstracts only.
Abstracts must not be more than 250 words.
Abstracts may contain no more than 1 table, for review purposes only, by clicking the image icon in the Objective, Methods, Results or Conclusions section. Table will not be published.
Abstracts must be submitted in English.
Abstracts must be typed in or can be copy and pasted from a plain text editor only.
Each submission should include the following headings in bold:
- Objective – state concisely why the study was conducted.
- Methods – indicate the type of study design, setting, location, patients, interventions or exposures, comparators, outcome measures, and statistics.
- Results – indicate the primary outcome of the study and statistical significance/major limitations; it is not satisfactory to state, “The results will be discussed.”
- Conclusions – state the main conclusions of the study, the significance of the results and the implications of how the results may affect patient management, or our understanding of the condition.

Ethics of Research and Presentation

Authors of reports of original research should present an accurate account of the work performed and an objective discussion of its importance. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
If the work involves the use of animal subjects, the author should ensure that the work described was conducted in accordance with the position of the American Association for the Advancement for Science in requiring assurances of the responsible use of animals in research.
If the work involves human subjects, the author should ensure that the work described was conducted in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. A statement of IRB approval or waiver must be included for research involving humans.
The privacy rights of human subjects must always be observed. Patients must not be identified by name or initials. No other information, including clinical photos or family trees, from which a patient could be identified is permitted unless express written permission from the patient/family is provided at the time of manuscript submission.
Appropriate consents, permissions, and releases must be obtained when an author wishes to include case details or other personal information or images of patients and any other individuals. Unless written permission from the patient (or, where applicable, the next of kin) exists, the personal details of any patient included in any part of the report and in any supplementary materials (including all illustrations and videos) must be removed before submission. To respect patients and any other individual’s privacy, do not send signed consent forms to ASCCP. Retain the signed form(s) in the event they should be needed.

Disclosure

A conflict of interest may exist when an author or the author’s institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work.
All authors relevant financial relationships must be declared at the time of abstract submission. If an author is employed by a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients which may include pharmaceutical companies, device manufacturers or distributors, service companies, or other for-profit entities), the abstract should apply to be a POSTER only.

Peer Review

All submissions will be peer reviewed anonymously by members of ASCCP, based on: scientific merit, originality, and relevancy to cervical pathology, colposcopy, and anogenital and HPV-related diseases.
- Scientific Merit: Is the study design appropriate to the study aims? How strong are the research methods with respect to selection of participant (inclusion/exclusion) and procedures used to assess outcome measures? Is the analytic approach appropriate to the study goals? Do the study conclusions flow from the results? Are study limitations recognized? Is the research study presented in a clear and easily understandable manner?
- Originality: Is the study innovative? Does the project challenge and shift current research or clinical practice paradigms by utilizing novel theoretic concepts, approaches or methodologies, instrumentation or interventions? Are the results newsworthy?
- Relevancy: Does the project impact an important problem or a critical barrier to progress in the field of lower Ano Urogenital tract disease? Does the project improve scientific knowledge, technical capability and/or clinical practice? Does the project change the concepts, methods, technologies, treatments, services, or preventative interventions that drive the field of lower Ano Urogenital tract disease? Are the goals of the science, the findings, and the interpretation readily accessible to the audience?

Notification of Receipt and Acceptance

Receipt of abstract submissions will be sent via email to the submitting author.
Authors selected to present at the ASCCP 2027 Annual Meeting will be required to confirm the availability of the presenting author to present at the meeting and must provide digital presentations by February 26, 2027.

Ownership and use of Materials

As between the ASCCP and you, you will be the sole owner of any materials developed, submitted and/or used by you in connection with the Event (the “Materials”). You represent and warrant (a) that the Materials are factually accurate and contain no libelous or otherwise unlawful statements; (b) that you are the sole author and owner of the Materials and/or have obtained the right to use and license the Materials as contemplated hereunder (e.g., from your employer, third-party content owner(s), etc.); and (c) that such use and license will not violate the proprietary or personal rights of any third party (including, without limitation, copyrights, trademarks or privacy rights). While you will own and may use without restriction the Materials you develop and submit, nothing herein shall be construed as granting you permission to use any materials or intellectual property belonging to ASCCP, including, without limitation, its name, logos, trademarks, copyrighted materials, photographs, or video or audio recordings, or any materials developed or submitted by and belonging to any ASCCP faculty member.

Your Grant of Rights to the ASCCP. You grant to the ASCCP and its designees the following rights and licenses on a non-exclusive, irrevocable, worldwide, sub-licensable basis:

· The right to record your presentation(s) and/or Materials on audio/video, and to reproduce, distribute, live stream, sell and otherwise make available transcripts, copies, on-demand products and audio/video recordings of the same, in whole or in part, for any and all lawful purposes and in any form or format, including, without limitation, print, current and future electronic media, social media platforms, and the internet and other online networks (collectively, “Format”);

· If applicable, the right to reproduce, distribute, sell and otherwise make available transcripts, copies, and on-demand products of the presentation(s) and/or Materials that you have pre-recorded and submitted to the ASCCP, in whole or in part, for any and all lawful purposes and in any Format;

· The right for your presentation(s) and/or Materials to be presented by other speakers if this Agreement is terminated early or if you are unable to attend the Event due to illness, death of a family member, or as determined by the ASCCP;

· The right to use your name, likeness, image, photograph and biographical data in connection with the promotion and distribution of the presentation(s) and/or Materials and any ASCCP activities related thereto;

· The right to include all or part of the presentation(s) and/or Materials in presentation slides, handouts and other Event materials, which are made available in any Format and the right to revise the Materials as deemed appropriate for inclusion thereof; and

· The right to make the presentation(s) and/or Materials available in any Format and to make derivatives of all or part of the presentation(s) and/or Materials in any Format and to use the same for any of the purposes described in this Section.

Withdrawls

Should abstract be published in another journal prior to ASCCP’s Annual Meeting, author must immediately withdraw their abstract.
Authors may withdraw their abstract until January 31, 2027. After that date, ASCCP will not be able to remove the abstracts from publication.

ABSTRACT SUBMISSION & GUIDLINES

Categories